Board of Directors
Chairman of the Board
James M. Weaver
Mr. Weaver is Vice President of Alticor Corporate Enterprises, a member of the Alticor Inc. family of companies. He is responsible for managing the current portfolio of companies and directs all acquisition and growth. Prior to joining Alticor, Mr. Weaver worked for X-Rite Inc. holding numerous leadership positions including Senior Vice President and General Manager, Vice President of marketing and software development, Vice President of marketing and product development, and also was the lead executive on several acquisitions. Mr. Weaver also founded and held the position of President and Chief Executive Officer of Bold Furniture Inc, and has held various leadership roles at Steelcase Inc. and Bissell Inc. Mr. Weaver received a bachelor’s degree in general studies from the University of Michigan in Ann Arbor. He also completed a consumer marketing course at the Kellogg School of Management at Northwestern University in Evanston, Ill. He holds professional memberships in the American Marketing Association, the Product Development Management Association, and the Design Management Institute, and serves on several non-profit and private company boards. Mr. Weaver joined Interleukin Genetics September 2007 as Chairman of the Board.
Board Member
Glenn S. Armstrong, Ph D.
Glenn S. Armstrong, Ph D., is Vice President of Corporate/Business Innovations for Alticor Inc. and leads Alticor’s Growth Through Innovation initiative. He joined Alticor in July 2007 from the Wm. Wrigley Jr. Company, where he was Senior Director and lead scientist of the company’s New Ventures Group & Mergers and Acquisitions. Dr. Armstrong is the former founder and president of Armstrong Sargent Group, Inc., a marketing, research and development, and technology assessment consulting firm. He also held marketing, innovation and product development, and science research positions with Whirlpool Corp., Quaker Oats Company, and General Mills, Inc. Dr. Armstrong earned a Bachelor of Science degree in botany from Eastern Illinois University in Charleston, Illinois. He received a Master of Science degree in food science, and a Ph.D. in food science from Purdue University in West Lafayette, Indiana. He also studied with a research team as a research chemist at Massachusetts Institute of Technology. He joined the Board of Directors as a Series A Director effective July 24, 2008.
Board Member
Lewis H. Bender
Lewis H. Bender joined Interleukin Genetics, Inc. as CEO in January of 2008. Prior to joining Interleukin Genetics, Mr. Bender was the Chief Technology Officer and CEO of Emisphere Technologies Inc. During his career, Mr. Bender has been the lead negotiator for several complex business agreements that were executed including out-licensing partnerships, in-licensing agreements, international joint venture agreements, asset acquisitions and stock purchases agreements with major pharmaceutical and biotechnology companies. The combined deals totaled over $200 million in milestone and upfront payments. He has been responsible for the management of all core product development functional areas including; discovery chemistry, process chemistry, analytical chemistry, manufacturing, pharmaceutics, project management, clinical research, and regulatory affairs. Mr. Bender has earned both a Bachelor of Science Degree and a Master of Science degree in chemical engineering from MIT. In addition, Mr. Bender also has earned an MBA from the Wharton School and a Masters of Fine Arts in International Relations at the University of Pennsylvania. He joined the Board of Directors as a Class II Director effective July 24, 2008.
Board Member
George D. Calvert
George D. Calvert is the Vice President, Research & Development/Quality Assurance of Access Business Group LLC, a product development, manufacturing and distribution company, and wholly owned subsidiary of Alticor Inc. He has held this position for the past seven years. Dr. Calvert has previously held the positions of Director Quality Assurance/Analytical Services with Access Business Group LLC, and Senior Manager Home Tech Research & Development with Amway Corporation. Dr. Calvert earned a Ph.D. in Analytical Chemistry from the University of South Carolina and a Bachelor of Science degree in Chemistry from the College of William and Mary. He joined the Board of Directors as a Series A Director effective March 24, 2003.
Board Member
Mary E. Chowning
Mary E. Chowning served as Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 28, 2003 to July 5, 2006. Ms. Chowning served as an Executive Vice President, Chief Financial Officer and Secretary of X-Rite Inc., from July 5, 2006 to March 3, 2008 and also served as its Principal Accounting Officer from July 28, 2003 to March 3, 2008. Prior to X-Rite, she co-founded the Wind River group of companies and served as its Managing Member, as well as its Chief Financial Officer for four years. Ms. Chowning began her career with Arthur Andersen LLP and spent 14 years in Public Accounting where she served in various positions of increasing responsibility with public and private clients in manufacturing, consumer products, technology and various service industries. She was made a Partner in the firm in 1996. Ms. Chowning is currently a member of the Board of Directors of Fincor Holdings, Inc., a privately held medical malpractice insurance and consulting company. Ms. Chowning is a graduate of the University of California where she holds a Bachelor of Arts in Economics. She is a Certified Public Accountant in California and a member of the American Institute of Certified Public Accountants. She joined the Board of Directors as a Class III Director effective July 24, 2008.
Board Member
Thomas R. Curran, Jr
Thomas R. Curran, Jr. is the Associate General Counsel/Corporate Development and Commercial Transactions of Alticor Inc., a company engaged in the principal business, through its affiliates, of offering products, business opportunities, and manufacturing and logistics services in more than 80 countries and territories worldwide, and which is the parent of Pyxis Innovations, Inc. He has held this position for the past seven years. He also holds the position of Chief Legal Officer for Access Business Group LLC, a manufacturing and distribution company and wholly owned subsidiary of Alticor Inc. Prior to joining Alticor, Mr. Curran was a partner in the law firm of Howard & Howard in Bloomfield Hills, Michigan. From 1982 to 1991, Mr. Curran worked for the Polaroid Corporation in various domestic and international financial and managerial positions. Mr. Curran holds a Bachelor of Arts from Providence College, a Master of International Management from the American Graduate School of International Management, and a Juris Doctorate from Suffolk University Law School. He joined the Board of Directors as a Series A Director effective March 24, 2003.
Board Member
Kenneth S. Kornman, DDS, Ph.D.
Kenneth S. Kornman, DDS, Ph.D, founder of the company and currently holds the positions of President and Chief Scientific Officer. Prior to founding the company in 1986, Dr. Kornman was a Department Chair and Professor at the University of Texas Health Science Center at San Antonio. He has also been a consultant and scientific researcher for many of the major oral care and pharmaceutical companies. Dr. Kornman currently holds academic appointments at Harvard University. He holds seven patents in the pharmaceutical area, has published two books and more than 100 articles, and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman holds a B.A. in Economics from Duke University. He obtained a D.D.S. from Emory University. Dr. Kornman also holds an M.S. (Periodontics) and a Ph.D. (Microbiology) from the University of Michigan. He joined the Board of Directors in August, 2006.